A Phase II, Placebo Controlled, Clinical Trial of Topical TolaSure Targeting Aggregated Mutant Keratin in Epidermolysis Bullosa Simplex — StellaPhase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.
Trial locations(2 sites)
United States
Stanford University School of Medicine, Dermatology Department, Palo Alto, California NU Dermatolgy CTU, Chicago, Illinois Age range
4 Years and older
Last updated September 2025